Raymond Debbane Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

Raymond Debbane is Director of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.39 Million shares of LXRX, which is worth approximately $1.03 Million. The most recent transaction as insider was on May 13, 2025, when has been sold 36,810 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.39M

2.73% 3M change

2.73% 12M change

Total Value Held $1.03 Million

RAYMOND DEBBANE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2025	BUY Exercise of conversion of derivative security	-	36,810 Added 2.59%	1,385,689 Common Stock
Apr 28 2024	BUY Exercise of conversion of derivative security	-	8,032 Added 0.59%	1,348,879 Common Stock
Oct 12 2023	BUY Open market or private purchase	$153,284 $1.03 p/Share	148,820 Added 9.99%	1,340,847 Common Stock
Oct 11 2023	BUY Open market or private purchase	$370,303 $1.08 p/Share	342,874 Added 22.34%	1,192,027 Common Stock
Oct 10 2023	BUY Open market or private purchase	$579,468 $1.14 p/Share	508,306 Added 37.45%	849,153 Common Stock
May 21 2023	BUY Exercise of conversion of derivative security	-	9,302 Added 2.66%	340,847 Common Stock
Apr 30 2022	BUY Exercise of conversion of derivative security	-	4,024 Added 1.2%	331,545 Common Stock
Apr 24 2021	BUY Exercise of conversion of derivative security	-	10,638 Added 3.15%	327,521 Common Stock

Also insider at

WW INTERNATIONAL, INC. Consumer Cyclical

Raymond Debbane

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX

Account